Two Sigma Advisers’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.01M | Buy |
|
|||||
2025
Q1 | $493K | Sell |
|
|||||
2024
Q4 | $25M | Sell |
|
|||||
2024
Q3 | $209M | Sell |
|
|||||
2024
Q2 | $429M | Buy |
|
|||||
2024
Q1 | $372M | Buy |
|
|||||
2023
Q4 | $94.7M | Sell |
|
|||||
2023
Q3 | $278M | Sell |
|
|||||
2023
Q2 | $307M | Sell |
|
|||||
2023
Q1 | $434M | Buy |
|
|||||
2022
Q4 | $433M | Sell |
|
|||||
2022
Q3 | $362M | Buy |
|
|||||
2022
Q2 | $341M | Buy |
|
|||||
2022
Q1 | $273M | Buy |
|
|||||
2021
Q4 | $250M | Sell |
|
|||||
2021
Q3 | $330M | Buy |
|
|||||
2021
Q2 | $1.58M | Buy |
|
|||||
2020
Q4 | – | Sell |
|
|||||
2020
Q3 | $367K | Sell |
|
|||||
2020
Q2 | $9.71M | Sell |
|
|||||
2020
Q1 | $11.7M | Sell |
|
|||||
2019
Q4 | $209M | Sell |
|
|||||
2019
Q3 | $298M | Sell |
|
|||||
2019
Q2 | $354M | Buy |
|
|||||
2019
Q1 | $254M | Buy |
|
|||||
2018
Q4 | $69.1M | Buy |
|
|||||
2018
Q3 | $5.66M | Sell |
|
|||||
2018
Q2 | $6.44M | Sell |
|
|||||
2018
Q1 | $11.3M | Sell |
|
|||||
2017
Q4 | $53.6M | Sell |
|
|||||
2017
Q3 | $268M | Sell |
|
|||||
2017
Q2 | $301M | Buy |
|
|||||
2017
Q1 | $273M | Buy |
|
|||||
2016
Q4 | $242M | Buy |
|
|||||
2016
Q3 | $223M | Buy |
|
|||||
2016
Q2 | $154M | Sell |
|
|||||
2016
Q1 | $191M | Buy |
|
|||||
2015
Q4 | $46.4M | Sell |
|
|||||
2015
Q3 | $154M | Buy |
|
|||||
2015
Q2 | $140M | Sell |
|
|||||
2015
Q1 | $132M | Buy |
|
|||||
2014
Q4 | $23.3M | Sell |
|
|||||
2014
Q3 | $48.6M | Buy |
|
|||||
2014
Q2 | $710K | Buy |
|
|||||
2014
Q1 | – | Sell |
|
|||||
2013
Q4 | $3.93M | Buy |
|
|||||
2013
Q3 | $724K | Buy |
|
|||||
2013
Q2 | $442K | Buy |
|